Immunophenotyping in multiple myeloma and related plasma cell disorders.
Plasma cell disorders form a spectrum ranging from the asymptomatic presence of small monoclonal populations of plasma cells to conditions like plasma cell leukemia and multiple myeloma, in which the bone marrow can be replaced by the accumulation of neoplastic plasma cells. Immunophenotyping has become an invaluable tool in the management of hematological malignancies and is increasingly finding a role in the diagnosis and monitoring of plasma cell disorders. Multiparameter flow cytometry has evolved considerably during the past decade with an increasing ability to screen large numbers of events and to detect multiple antigens at the same time. This, along with a better understanding of the phenotypic heterogeneity of the clonal plasma cells in different disorders, has made immunophenotyping an indispensible tool in the diagnosis, prognostic classification and management of plasma cell disorders. This book chapter addresses the approaches taken to evaluate monoclonal plasma cell disorders, and the different markers and techniques that are important for the study of these diseases.
Divisions of Hematology and Hematopathology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, United States. kumar.shaji@mayo.edu
Shaji
S
Kumar
Teresa
T
Kimlinger
William
W
Morice
D005434:Flow Cytometry; D006801:Humans; D016130:Immunophenotyping / Q000379:methods; D009101:Multiple Myeloma / Q000473:pathology*; D054219:Neoplasms, Plasma Cell / Q000473:pathology*